September 29, 2022

Volume XII, Number 272

Paul Ranson

Paul Ranson is a consultant who focuses on the regulatory and commercial needs of the pharmaceutical, biotechnology, and medical devices sectors. Paul’s regulatory expertise covers both marketing authorisation-related matters and market access, pricing, and reimbursement issues. His commercial work is concentrated on transactions with a high degree of industry specificity including collaborations and outsourcing transactions.

Articles in the National Law Review database by Paul Ranson